Advanced Cell Technology to Host Conference Call to Discuss 2013 Third Quarter Results & Provide a Corporate Update on Tuesda...
November 12 2013 - 11:17AM
Business Wire
Webcast Scheduled for 4:30 p.m. Eastern
Time
Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a
leader in the field of regenerative medicine, announced today that
it will release its third quarter financial results for the period
ended September 30, 2013 after the market closes and hold a
conference call on Tuesday, November 12th, 2013 at 4:30 p.m. EST
during which it will discuss these results and provide a corporate
update.
Interested parties may access the call live by dialing (888)
264-3177 and using conference ID 14878582. This event is also being
streamed via webcast. The webcast is available
at http://us.meeting-stream.com/advancedcelltechnology111213.
A replay of the call will also be available via the same link.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc., is a biotechnology company
applying cellular technology in the field of regenerative medicine.
For more information, http://www.advancedcell.com or connect with
the Company on Facebook, Twitter, LinkedIn, Google+, and
YouTube.
Forward-Looking Statements
Statements in this news release regarding future financial and
operating results, future growth in research and development
programs, potential applications of our technology, opportunities
for the company and any other statements about the future
expectations, beliefs, goals, plans, or prospects expressed by
management constitute forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Any
statements that are not statements of historical fact (including
statements containing the words “will,” “believes,” “plans,”
“anticipates,” “expects,” “estimates,” and similar expressions)
should also be considered to be forward-looking statements. There
are a number of important factors that could cause actual results
or events to differ materially from those indicated by such
forward-looking statements, including: limited operating history,
need for future capital, risks inherent in the development and
commercialization of potential products, protection of our
intellectual property, and economic conditions generally.
Additional information on potential factors that could affect our
results and other risks and uncertainties are detailed from time to
time in the company’s periodic reports, including the report on
Form 10-K for the year ended December 31, 2012. Forward-looking
statements are based on the beliefs, opinions, and expectations of
the company’s management at the time they are made, and the company
does not assume any obligation to update its forward-looking
statements if those beliefs, opinions, expectations, or other
circumstances should change. Forward-looking statements are based
on the beliefs, opinions, and expectations of the company’s
management at the time they are made, and the company does not
assume any obligation to update its forward-looking statements if
those beliefs, opinions, expectations, or other circumstances
should change. There can be no assurance that the Company’s
clinical trials will be successful.
Investors:CEOcast, Inc.Bob Woods, 212-732-4300orPress:Russo
PartnersDavid Schull, 858-717-2310